Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA
Open Access
- 21 February 2024
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 20 (16) , 1079-1097
Abstract
Aim: Real-world treatment patterns in tenosynovial giant cell tumor (TGCT) patients remain unknown. Pexidartinib is the only US FDA-approved treatment for TGCT associated with severe morbidity or f... Plain language summary – Treatment patterns in patients with tenosynovial giant cell tumors in the USA This database study is the first investigation of how drugs are used to treat patients with te...Keywords
This publication has 45 references indexed in Scilit:
- Real‐world treatment patterns of metastatic non‐small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitorsCancer Medicine, 2022
- Long‐term outcomes of pexidartinib in tenosynovial giant cell tumorsCancer, 2020
- Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck RegionHead and Neck Pathology, 2020
- Burden of Illness Associated with Tenosynovial Giant Cell TumorsClinical Therapeutics, 2018
- Patient-reported Symptoms of Tenosynovial Giant Cell TumorsClinical Therapeutics, 2016
- Tenosynovial giant cell tumour/pigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitorsEuropean Journal of Cancer, 2015
- A multidisciplinary approach to giant cell tumors of tendon sheath and synovium—A critical appraisal of literature and treatment proposalJournal of Surgical Oncology, 2012
- Giant Cell Tumour of Tendon Sheath of the Digits. A Systematic ReviewHAND, 2011
- Outcomes after Excision of Pigmented Villonodular Synovitis of the KneeClinical Orthopaedics and Related Research, 2009
- Giant cell tumor of the tendon sheath (nodular tenosynovitis): A study of 207 cases to compare the large joint group with the common digit groupCancer, 1986